- Home
- NMRK vs INVA Comparison
NMRK vs INVA Comparison
Compare NMRK & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMRK | INVA |
|---|---|---|
| Founded | 1929 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 2017 | 2000 |
Fundamental Metrics
Financial Performance| Metric | NMRK | INVA |
|---|---|---|
| Price | $11.86 | $19.61 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | $16.75 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 2.1M | 620.2K |
| Earning Date | 10-29-2026 | 11-04-2026 |
| Dividend Yield | ★ 1.94% | N/A |
| EPS Growth | 100.00 | ★ 816.67 |
| EPS | 0.18 | ★ 0.40 |
| Revenue | ★ $3,294,024,000.00 | $217,217,000.00 |
| Revenue This Year | $14.54 | $9.72 |
| Revenue Next Year | $6.15 | $8.58 |
| P/E Ratio | $68.67 | ★ $17.01 |
| Revenue Growth | 20.29 | ★ 62.63 |
| 52 Week Low | $11.13 | $19.00 |
| 52 Week High | $18.25 | $25.15 |
Technical Indicators
Market Signals| Indicator | NMRK | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 52.43 | 53.86 |
| Support Level | $11.26 | $20.42 |
| Resistance Level | $16.13 | $21.69 |
| Average True Range (ATR) | 0.47 | 0.45 |
| MACD | 0.16 | 0.02 |
| Stochastic Oscillator | 83.11 | 65.79 |
Price Performance
Historical ComparisonAbout NMRK Newmark Group Inc.
Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.